Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function

V. Samanna, T. Ma, T. W. Mak, M. Rogers, M. A. Chellaiah

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

CD44 and MMP-9 are implicated in cell migration. In the current study, we tested the hypothesis that actin polymerization is critical for CD44 surface expression and MMP-9 activity on the cell surface. To understand the underlying molecular mechanisms involved in CD44 surface expression and MMP-9 activity on the cell surface, osteoclasts were treated with bisphosphonate (BP) alendronate, cytochalasin D (Cyt D), and a broad-spectrum MMP inhibitor (GM600 1). BP has been reported to block the mevalonate pathway, thereby preventing prenylation of small GTPase signaling required for actin cytoskeleton modulation. We show in this study that osteoclasts secrete CD44 and MMP-9 into the resorption bay during migration and bone resorption. Results indicate that actin polymerization is critical for CD44 surface expression and osteoclast function. In particular, the surface expression of CD44 and the membrane activity of MMP-9 are reduced in osteoclasts treated with alendronate and Cyt D despite the membrane levels of MMP-9 being unaffected. Although GM600 1 blocked MMP-9 activity, osteoclast migration, and bone resorption, the surface levels of CD44 were unaffected. We suggest that the surface expression of CD44 requires actin polymerization. Disruption of poclosome and actin ring structures by Cyt D and alendronate not only resulted in reduced localization of MMIP-9 in these structures but also in osteoclast migration and bone resorption. These results suggest that inhibition of actin polymerization by alendronate and Cyt D is effective in blocking CD44/MMP-9 complex formation on the cell surface, secretion of active form of MMP-9, and osteoclast migration. CD44/MMP-9 complex formation may signify a unique motilityenhancing signal in osteoclast function.

Original languageEnglish
Pages (from-to)710-720
Number of pages11
JournalJournal of Cellular Physiology
Volume213
Issue number3
Early online date16 May 2007
DOIs
Publication statusPublished - Dec 2007

Keywords

  • membrane-type-1 matrix-metalloproteinase
  • tumor-cell migration
  • hemopexin-like domain
  • FC-gamma-RIIIB
  • bone-resorption
  • signaling pathways
  • hyaluronic-acid
  • melanoma-cells
  • gelatinase-B
  • cancer cells

Cite this

Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function. / Samanna, V.; Ma, T.; Mak, T. W.; Rogers, M.; Chellaiah, M. A.

In: Journal of Cellular Physiology, Vol. 213, No. 3, 12.2007, p. 710-720.

Research output: Contribution to journalArticle

Samanna, V. ; Ma, T. ; Mak, T. W. ; Rogers, M. ; Chellaiah, M. A. / Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function. In: Journal of Cellular Physiology. 2007 ; Vol. 213, No. 3. pp. 710-720.
@article{de60d46d29ed4c31a9e3448a9bfb20ad,
title = "Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function",
abstract = "CD44 and MMP-9 are implicated in cell migration. In the current study, we tested the hypothesis that actin polymerization is critical for CD44 surface expression and MMP-9 activity on the cell surface. To understand the underlying molecular mechanisms involved in CD44 surface expression and MMP-9 activity on the cell surface, osteoclasts were treated with bisphosphonate (BP) alendronate, cytochalasin D (Cyt D), and a broad-spectrum MMP inhibitor (GM600 1). BP has been reported to block the mevalonate pathway, thereby preventing prenylation of small GTPase signaling required for actin cytoskeleton modulation. We show in this study that osteoclasts secrete CD44 and MMP-9 into the resorption bay during migration and bone resorption. Results indicate that actin polymerization is critical for CD44 surface expression and osteoclast function. In particular, the surface expression of CD44 and the membrane activity of MMP-9 are reduced in osteoclasts treated with alendronate and Cyt D despite the membrane levels of MMP-9 being unaffected. Although GM600 1 blocked MMP-9 activity, osteoclast migration, and bone resorption, the surface levels of CD44 were unaffected. We suggest that the surface expression of CD44 requires actin polymerization. Disruption of poclosome and actin ring structures by Cyt D and alendronate not only resulted in reduced localization of MMIP-9 in these structures but also in osteoclast migration and bone resorption. These results suggest that inhibition of actin polymerization by alendronate and Cyt D is effective in blocking CD44/MMP-9 complex formation on the cell surface, secretion of active form of MMP-9, and osteoclast migration. CD44/MMP-9 complex formation may signify a unique motilityenhancing signal in osteoclast function.",
keywords = "membrane-type-1 matrix-metalloproteinase, tumor-cell migration, hemopexin-like domain, FC-gamma-RIIIB, bone-resorption, signaling pathways, hyaluronic-acid, melanoma-cells, gelatinase-B, cancer cells",
author = "V. Samanna and T. Ma and Mak, {T. W.} and M. Rogers and Chellaiah, {M. A.}",
year = "2007",
month = "12",
doi = "10.1002/jcp.21137",
language = "English",
volume = "213",
pages = "710--720",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function

AU - Samanna, V.

AU - Ma, T.

AU - Mak, T. W.

AU - Rogers, M.

AU - Chellaiah, M. A.

PY - 2007/12

Y1 - 2007/12

N2 - CD44 and MMP-9 are implicated in cell migration. In the current study, we tested the hypothesis that actin polymerization is critical for CD44 surface expression and MMP-9 activity on the cell surface. To understand the underlying molecular mechanisms involved in CD44 surface expression and MMP-9 activity on the cell surface, osteoclasts were treated with bisphosphonate (BP) alendronate, cytochalasin D (Cyt D), and a broad-spectrum MMP inhibitor (GM600 1). BP has been reported to block the mevalonate pathway, thereby preventing prenylation of small GTPase signaling required for actin cytoskeleton modulation. We show in this study that osteoclasts secrete CD44 and MMP-9 into the resorption bay during migration and bone resorption. Results indicate that actin polymerization is critical for CD44 surface expression and osteoclast function. In particular, the surface expression of CD44 and the membrane activity of MMP-9 are reduced in osteoclasts treated with alendronate and Cyt D despite the membrane levels of MMP-9 being unaffected. Although GM600 1 blocked MMP-9 activity, osteoclast migration, and bone resorption, the surface levels of CD44 were unaffected. We suggest that the surface expression of CD44 requires actin polymerization. Disruption of poclosome and actin ring structures by Cyt D and alendronate not only resulted in reduced localization of MMIP-9 in these structures but also in osteoclast migration and bone resorption. These results suggest that inhibition of actin polymerization by alendronate and Cyt D is effective in blocking CD44/MMP-9 complex formation on the cell surface, secretion of active form of MMP-9, and osteoclast migration. CD44/MMP-9 complex formation may signify a unique motilityenhancing signal in osteoclast function.

AB - CD44 and MMP-9 are implicated in cell migration. In the current study, we tested the hypothesis that actin polymerization is critical for CD44 surface expression and MMP-9 activity on the cell surface. To understand the underlying molecular mechanisms involved in CD44 surface expression and MMP-9 activity on the cell surface, osteoclasts were treated with bisphosphonate (BP) alendronate, cytochalasin D (Cyt D), and a broad-spectrum MMP inhibitor (GM600 1). BP has been reported to block the mevalonate pathway, thereby preventing prenylation of small GTPase signaling required for actin cytoskeleton modulation. We show in this study that osteoclasts secrete CD44 and MMP-9 into the resorption bay during migration and bone resorption. Results indicate that actin polymerization is critical for CD44 surface expression and osteoclast function. In particular, the surface expression of CD44 and the membrane activity of MMP-9 are reduced in osteoclasts treated with alendronate and Cyt D despite the membrane levels of MMP-9 being unaffected. Although GM600 1 blocked MMP-9 activity, osteoclast migration, and bone resorption, the surface levels of CD44 were unaffected. We suggest that the surface expression of CD44 requires actin polymerization. Disruption of poclosome and actin ring structures by Cyt D and alendronate not only resulted in reduced localization of MMIP-9 in these structures but also in osteoclast migration and bone resorption. These results suggest that inhibition of actin polymerization by alendronate and Cyt D is effective in blocking CD44/MMP-9 complex formation on the cell surface, secretion of active form of MMP-9, and osteoclast migration. CD44/MMP-9 complex formation may signify a unique motilityenhancing signal in osteoclast function.

KW - membrane-type-1 matrix-metalloproteinase

KW - tumor-cell migration

KW - hemopexin-like domain

KW - FC-gamma-RIIIB

KW - bone-resorption

KW - signaling pathways

KW - hyaluronic-acid

KW - melanoma-cells

KW - gelatinase-B

KW - cancer cells

U2 - 10.1002/jcp.21137

DO - 10.1002/jcp.21137

M3 - Article

VL - 213

SP - 710

EP - 720

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 3

ER -